This statement addresses the use of somatostatin-receptor ligands (SRLs) as preoperative therapy for individuals with acromegaly to improve outcomes.
Read Consensus Statement
2015 Consensus Statement for Pre-Operative Therapy in Management of Patients with Acromegaly